UBS analysts predict continued stock market growth in 2025, citing strong corporate performance, robust cash flow, and economic stability. They dismiss concerns about a downturn, pointing to the increased influence of tech companies and manageable borrowing costs. Bank of America shares this optimistic outlook, forecasting the S&P 500 to reach 6,666 by year-end 2025.
UBS Group AG has announced impressive financial results for the third quarter of 2024, exceeding analysts’ expectations on both revenue and earnings. This robust performance, coupled with strategic streamlining and asset management initiatives, has propelled UBS’s stock higher and solidified its position as a leader in the financial services industry.
American Express has expanded its partnership with Formula 1 from the Americas to a global level, aiming to enhance fan experiences and tap into the growing popularity of the motorsport among Millennials and Gen Z. This comes alongside American Express becoming the sole owner of Swisscard and reporting mixed third-quarter results.
UBS initiated coverage on Harmony Biosciences Holdings Inc (HRMY) with a Buy rating and a $56 price target, citing strong growth potential for its narcolepsy drug Wakix and a promising pipeline of CNS assets. The firm expects Wakix to achieve $1.2 billion in peak sales, driven by increased narcolepsy diagnosis and the drug’s unique profile in the polypharmacy market.
Swiss investment bank UBS downgraded ASML Holding NV, a leading Dutch chipmaker, from Buy to Neutral, citing slower earnings growth expectations in the coming years. This move follows a bloodbath in the US semiconductor sector on Tuesday and reflects concerns about declining demand for advanced chips. The downgrade sent ripples through US semiconductor stocks, with Nvidia, Intel, and AMD all experiencing significant losses.
UBS Group AG has decided to liquidate a real estate fund acquired from Credit Suisse, valued at over $2 billion. The decision comes after the fund’s value significantly declined throughout 2023, leading to substantial redemptions. UBS believes selling the remaining assets at this time would negatively impact remaining investors.
UBS Group AG (UBS) shares climbed in pre-market trading after reporting strong second-quarter 2024 results, exceeding expectations on revenue and profit. The results highlight the successful integration of Credit Suisse and demonstrate the bank’s commitment to achieving its financial targets. UBS also provided an outlook for the third quarter and second half of 2024, anticipating continued integration-related expenses and cost savings.
A new UBS Global Wealth Report predicts a decline in the number of dollar millionaires in Britain by 2028, while the US and Taiwan are set to see significant increases. The report attributes the shift to factors like tax policies, global wealth trends, and the booming microchip industry in Taiwan.
Japanese stocks are expected to soar in the coming months, with the Nikkei 225 projected to reach new record highs. According to analysts at UBS, the Nikkei is poised to close the year at 45,000 points, while the TOPIX index is set to hit 3,120 points. Export-oriented businesses are expected to lead the market rally, and the yen is predicted to continue its downward trend.
Texas Instruments’ (TXN) first-quarter results and guidance suggest an impending recovery in the semiconductor industry. Despite revenue declines, the company’s management expects some industrial end markets to reach the end of inventory corrections. TXN shares surged premarket, while rivals Analog Devices (ADI), NXP Semiconductors (NXPI), and ON Semiconductor (ON) also gained.
